Dabrafenib,an inhibitor of RIP3 kinase-dependent necroptosis,reduces ischemic brain injury

Shelly A. Cruz; Zhaohong Qin; Alexandre F. R. Stewart; Hsiao-Huei Chen

doi:10.4103/1673-5374.226394

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Dabrafenib,an inhibitor of RIP3 kinase-dependent necroptosis,reduces ischemic brain injury

DOI: 10.4103/1673-5374.226394

Dabrafenib,an inhibitor of RIP3 kinase-dependent necroptosis,reduces ischemic brain injury

Shelly A. Cruz

Zhaohong Qin

Alexandre F. R. Stewart

Hsiao-Huei Chen

Keywords：ischemic brain injuryinflammationmacrophageDabrafenibtumor necrosis factor-alphaphotothrombosisreceptor-interacting protein kinasesnecroptosismicrogliastrokeneural regeneration

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 252-256 )

Neural Regeneration Research

ISTICSCI

ISSN：1673-5374

Year, Vol.(Issue)：2018,13(2)